Skip to Content

T 150 (Tarceva 150 mg)

Generic Name: erlotinib

Pill with imprint T 150 is White, Round and has been identified as Tarceva 150 mg. It is supplied by Genentech.

Tarceva is used in the treatment of non-small cell lung cancer; pancreatic cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Tarceva 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for T 150

Tarceva

Generic Name
erlotinib
Imprint
T 150
Strength
150 mg
Color
White
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
EGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Genentech

Labelers / Repackagers

NDC CodeLabeler / Repackager
50242-0064 Genentech, Inc.
54868-5447 Physicians Total Care Inc. (repackager)
54569-5848 A-S Medication Solutions, LLC (repackager)

Get help with Imprint Code FAQs.

Related Images for "T 150"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.